(Q33382390)

26 July 2017

title

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study (English)

1 reference

systemic lupus erythematosus

26 July 2017

1 reference

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

S K Kwok

1

1 reference

26 July 2017

J H Ju

2

1 reference

26 July 2017

C S Cho

3

1 reference

26 July 2017

H Y Kim

4

1 reference

26 July 2017

S H Park

5

1 reference

26 July 2017

publication date

1 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

18

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

16-21

1 reference

Thrombotic thrombocytopenic purpura--then and now.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Systemic lupus erythematosus complicated by thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Thrombotic microangiopathies: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Acquired thrombotic thrombocytopenic purpura as the presenting symptom of systemic lupus erythematosus. Successful treatment with plasma exchange and immunosuppression--report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Recurrent thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus: clinical significance of anti-platelet antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Thrombotic thrombocytopenic purpura and systemic lupus erythematosus - distinct entities or overlapping syndromes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: Distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Molecular mechanisms in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308094360

21 January 2018

Identifiers

DOI

10.1177/0961203308094360

1 reference

26 July 2017

1 reference